Skip to main content
. 2021 Oct 24;12(11):1840–1846. doi: 10.1021/acsmedchemlett.1c00481

Figure 4.

Figure 4

NK007(S,R) and remdesivir (RDV) inhibit virus replication in lungs of COVID-19 hamster rats. (A) Schematic diagram of NK007(S,R) or remdesivir treated COVID-19 hamster rats. (B) Weight loss of infected rats treated with NK007 or remdesivir. (C) Viral RNA copies in rat lungs at day 4 (unpaired t test). (D) Histological scores of lung inflammation of NK007(S,R) or remdesivir treated SARS-CoV-2 infected rats (unpaired t test). (E) Representative hematoxylin-eosin (HE) staining of lungs from rats harvested at day 4. Bar: 100 μm.